Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
CXHL1301287	波舒替尼	bosutinib monohydrate	Active ingredient	Chemical Drugs(3.1)	New Drug Application	2014-01-10	山东创新药物研发有限公司	Shandong Innovative Drug Research and Development Co Ltd	Certificate Issued	2016-01-28	view
CXHL1301288	波舒替尼片	bosutinib monohydrate	Tablet	Chemical Drugs(3.1)	New Drug Application	2014-01-10	山东创新药物研发有限公司	Shandong Innovative Drug Research and Development Co Ltd	Certificate Issued	2016-01-28	view
CXHL1301289	波舒替尼片	bosutinib monohydrate	Tablet	Chemical Drugs(3.1)	New Drug Application	2014-01-10	山东创新药物研发有限公司	Shandong Innovative Drug Research and Development Co Ltd	Certificate Issued	2016-01-28	view
CXHL1500377	波舒替尼	bosutinib monohydrate	Active ingredient	Chemical Drugs(3.1)	New Drug Application	2015-04-09	济南百诺医药科技开发有限公司	Shandong Bestcomm Pharmaceutical Company Limited	Certificate Issued	2016-06-20	view
CXHL1500378	波舒替尼片	bosutinib monohydrate	Tablet	Chemical Drugs(3.1)	New Drug Application	2015-04-09	济南百诺医药科技开发有限公司	Shandong Bestcomm Pharmaceutical Company Limited	Certificate Issued	2016-06-20	view
CXHL1500379	波舒替尼片	bosutinib monohydrate	Tablet	Chemical Drugs(3.1)	New Drug Application	2015-04-09	济南百诺医药科技开发有限公司	Shandong Bestcomm Pharmaceutical Company Limited	Certificate Issued	2016-06-20	view